<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04244500</url>
  </required_header>
  <id_info>
    <org_study_id>UMR893958</org_study_id>
    <nct_id>NCT04244500</nct_id>
  </id_info>
  <brief_title>Burden of Influenza at Emergency Department (ED) Level in European Countries</brief_title>
  <official_title>Burden of Influenza at Emergency Department (ED) Level in European Countries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rostock</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Klinikum Ernst von Bergmann Potsdam</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum Suedstadt, Rostock</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sanofi Pasteur, a Sanofi Company</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Rostock</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study plans to conduct enhanced influenza surveillance at a hospital emergency
      department level independent of underlying influenza-like symptoms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study objectives

      Primary:

      - Measure the proportion of non-traumatic emergency department (ED) visits infected with
      influenza during the peak of the influenza season

      Secondary:

        -  Describe the demographic and medical profile of influenza-related and
           non-influenza-related visits

        -  Identify socio-demographic or other risk factors associated with ED visit outcome

        -  Describe the influenza positivity rate among ED visits for different causes

        -  Measure the proportion of influenza positive patients without classical ILI symptoms
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 27, 2020</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>influenza status at admission to ED (positive vs. negative)</measure>
    <time_frame>at admission to ED</time_frame>
    <description>proportion of non-traumatic emergency department (ED) visits infected with influenza during the peak of the influenza season</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>demographic and medical profile</measure>
    <time_frame>at admission to ED</time_frame>
    <description>demographic and medical profile of influenza-related and non-influenza-related visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>socio-demographic or other risk factors</measure>
    <time_frame>at admission to ED</time_frame>
    <description>Identify socio-demographic or other risk factors associated with ED visit outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>influenza without classical symptoms of influenza-like illness</measure>
    <time_frame>at admission to ED</time_frame>
    <description>Measure the proportion of influenza positive patients without classical ILI symptoms</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>Influenza, Human</condition>
  <arm_group>
    <arm_group_label>Influenza</arm_group_label>
    <description>Influenza testing</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>swab sampling</intervention_name>
    <description>Multiplex polymerase chain reaction assay for organisms of upper respiratory tract infections</description>
    <arm_group_label>Influenza</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients seeking care at the emergency department of participating hospitals
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adult patients seeking care at participating ED during the influenza season

          -  Participants and/or guardian providing informed consent and/or assent, as appropriate,
             to participate.

        Exclusion Criteria:

          -  Individuals reporting having suffered a traumatic injury without other conditions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Martin Bienengraeber, Dr.</last_name>
    <phone>+49 381 494 5031</phone>
    <email>dekanat.forschung@med.uni-rostock.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Bienengraeber, Dr.</last_name>
      <phone>+49381494 5031</phone>
      <email>dekanat.forschung@med.uni-rostock.de</email>
    </contact>
    <investigator>
      <last_name>Micha Loebermann, PD Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 12, 2020</study_first_submitted>
  <study_first_submitted_qc>January 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2020</study_first_posted>
  <last_update_submitted>January 26, 2020</last_update_submitted>
  <last_update_submitted_qc>January 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rostock</investigator_affiliation>
    <investigator_full_name>Dr. med. Micha Loebermann</investigator_full_name>
    <investigator_title>Deputy head of Department</investigator_title>
  </responsible_party>
  <keyword>emergency room</keyword>
  <keyword>epidemiology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

